Ilona Mihaela Liliac

Dr. Ilona Mihaela Liliac

Department of Histology, University of Medicine and Pharmacy of Craiova, Petru Rares Street 2, Craiova 200349, Romania
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
Bogdan Silviu UngureanuBogdan Silviu Ungureanu
Bogdan Silviu Ungureanu
CLCristian-Virgil Lungulescu
Cristian-Virgil Lungulescu
DPDaniel Pirici
Daniel Pirici
Adina Turcu-StiolicaAdina Turcu-Stiolica
Adina Turcu-Stiolica
DGDan Ionut Gheonea
Dan Ionut Gheonea
ASAdrian Saftoiu
Adrian Saftoiu
An increasing number of tumor markers have been discovered to have potential efficacy as diagnostic and prognostic tools in gastric cancer. We aimed to assess putative correlations between claudin 18.2 expression and pathological or prognosis features in patients with gastric cancer. MEDLINE, Web of Science, EBSCO, and ClinicalTrials.gov were used to search for relevant studies from their inception to 30 October 2020. Finally, a total of six articles were included in this meta-analysis. Review Manager 5 software was applied to examine the heterogeneity among the studies and to calculate the odds ratio with 95% CI by selecting corresponding models, in evaluating the strength of the relationship. Publication bias test was also conducted. No bias and no significant correlations were found between CLDN 18.2 and TNM stages, Lauren classification, HER2, grading, or overall survival. This meta-analysis expounded that the relationship with CLDN 18.2 and pathological features depends on the percentage of staining of tumor cells for which CLDN 18.2 is considered positive. Our pooled outcomes suggest that targeted therapy for CLDN 18.2 could be effective if certain criteria were established.

12 January 2022 in Romanian Journal of Morphology and Embryology
Verified
Journal Article
Open access
DDDamian Diţescu
Damian Diţescu
AIAnca-Maria Istrate-Ofiţeru
Anca-Maria Istrate-Ofiţeru
GRGabriela Camelia Rosu
Gabriela Camelia Rosu
LILarisa Iovan
Larisa Iovan
ILIlona Mihaela Liliac
Ilona Mihaela Liliac
LCLiliana Cercelaru
Liliana Cercelaru
Condyloma acuminatum (CA) is a pathology caused by the human papillomavirus (HPV). It is manifested by the appearance of warts in the vulvar, pubic, and anorectal regions, but can occur in other areas. It is a common disease that can be prevented by using measures such as condoms or vaccine. Topical, local, pharmacological, surgical, and excisional therapy options are available for this pathology. Macroscopically, it appears as a vegetative tumor, with a single implantation base that branches towards the periphery, with a cauliflower appearance. CA is defined microscopically by acanthosis, parakeratosis, papillomatosis and koilocytosis. Immunohistochemical studies can detect the presence of various HPV strains or viral antigens and can emphasize certain specific characteristics; e.g., in the case presented in this study, we observed that the tumor had a fulminant evolution due to a strong vascular base identified with anti-cluster of differentiation (CD) 34 antibody, by the existence of epithelial cells with a high degree of cell proliferation, as evidenced by the anti-Ki67 antibody, the inactivation of the tumor suppressor gene and the appearance of immunolabeling for the anti-p53 antibody, by the strong immunoreactivity for p63 which reveals the existence of cells with dysplastic and neoplastic transformation potential, but also by detecting the immunolabeling for p16INK4a that is associated with the existence of HPV. Also, the tumor was immunoreactive for cytokeratin (CK) AE1/AE3, partially immunoreactive for CK5/6 in the basal layer and negative for CK7, which demonstrates the squamous epithelial origin of the described tumor. Subepithelial cells of the inflammatory system have been identified, such as macrophages immunolabeled with anti-CD68 antibody, T-lymphocytes immunolabeled with anti-CD3 antibody and rare B-lymphocytes immunolabeled with anti-CD20 antibody, which demonstrates the strong cellular response to remove the virus from the structure. Surgical and excisional treatment was helpful for the patient, because she was able to resume normal sexual activity and defecation, and on the other hand, microscopic studies showed the potential for malignant transformation of CA.

6 May 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MMMarina Daniela Manescu
Marina Daniela Manescu
BCBogdan Catalin
Bogdan Catalin
IBIoana Baldea
Ioana Baldea
VMValentin Octavian Mateescu
Valentin Octavian Mateescu
RCRosu Camelia
Rosu Camelia
DPDaniel Pirici
Daniel Pirici
INTRODUCTION: Deficiency in the aquaporin‐4 (AQP4) water channel has been linked to impaired amyloid beta (Aβ) clearance. However, a detailed morphopathological analysis of amyloid deposition following AQP4 therapeutic modulation remains unexplored.METHODS: Two‐month‐old amyloid precursor protein presenilin 1 (APPPS1) mice were treated daily for 28 days with either the AQP4 facilitator N‐(3‐(Benzyloxy)pyridin‐2‐yl) benzene‐sulfonamide (TGN‐073) or the AQP4 inhibitor N‐(1,3,4‐thiadiazol‐2‐yl)pyridine‐3‐carboxamide dihydrochloride (TGN‐020) (both at 200 mg/kg). Controls included vehicle‐treated APPPS1 and WT C57BL/6J mice. Comprehensive histopathological, biochemical, and behavioral analyses were conducted.RESULTS: Mice treated with AQP4 facilitator showed a significant reduction in total Aβ, fibrillar deposits, and soluble Aβ, while the AQP4 inhibitor caused a substantial increase in brain Aβ. AQP4‐facilitator treatment also reduced Aβ40 levels and Aβ40/Aβ42 ratio, whereas the inhibitor treatment increased both Aβ40 and Aβ42. Additionally, facilitator‐treated mice demonstrated reduced anxiety and improved memory performance.DISCUSSION: These findings suggest that AQP4 modulation is a promising strategy to enhance Aβ clearance and a potential therapeutic target in Alzheimer's disease.Highlights: Intramural periarterial drainage of the interstitial fluid mediated by aquaporin‐4 (AQP4) is a key element that ensures clearance of catabolites/Aβ peptide from within the brain parenchyma. Inhibition of AQP4 in an APPPS1 mouse model of AD leads to increased amyloid deposition and deficient behavior compared to untreated transgenic animals. Pharmaceutical facilitation of AQP4 in the same APPPS1 mouse model leads to a massive decrease in amyloid burden and improves the behavioral performance of the animals compared to untreated control APPPS1 mice.

13 February 2025 in Romanian Journal of Morphology and Embryology
Verified
Journal Article
Open access
ARAlina Cristina Rădeanu
Alina Cristina Rădeanu
ILIlona Mihaela Liliac
Ilona Mihaela Liliac
MMMaria Cristina Munteanu
Maria Cristina Munteanu
MSMihai Surpăţeanu
Mihai Surpăţeanu
CPCiprian Laurenţiu Pătru
Ciprian Laurenţiu Pătru
EAElena Cristina Andrei
Elena Cristina Andrei
The oral mucosa can suffer a series of traumatic injuries from various causes (bacterial plaque, tartar, fillings, incorrectly adapted prosthesis). A risk factor generating periodontal diseases is represented by fixed orthodontic therapy, if the forces exerted on it are excessive. These forces cause more or less extensive injuries both on the surface and in depth. One of these lesions is gingival hypergrowth. Early injuries concern only the superficial periodontium and are represented by mild or moderate inflammation, gingival hypergrowth, which can be reversible after removing the irritating factor (bacterial plaque, tartar). Advanced injuries are characterized by major clinical, radiological and tissue changes that cause the destruction of the deep periodontium (alveolar bone, deep ligament). Hypergrowth changes may occur at the epithelial level with reduced conjunctival reaction or may predominantly involve fibro-connective structures of the chorion with insignificant reaction in the epithelial component. Through this study, we highlight superficial and deep changes at the gingival and periodontal level.

13 February 2025 in Romanian Journal of Morphology and Embryology
Verified
Journal Article
Open access
CCCristian Niky Cumpătă
Cristian Niky Cumpătă
MMMaria Cristina Munteanu
Maria Cristina Munteanu
EAElena Cristina Andrei
Elena Cristina Andrei
ILIlona Mihaela Liliac
Ilona Mihaela Liliac
CBCristina Jana Busuioc
Cristina Jana Busuioc
ABAlexandru Burcea
Alexandru Burcea
Pindborg tumor is a calcifying epithelial odontogenic tumor possibly arising from developmental disturbances in dental lamina remnants. It predominantly affects individuals in their third decade of life, with women also experiencing later onset. The tumor exists in two forms, namely intraosseous (central) and extraosseous (peripheral), with the former showing higher post-surgery recurrence rates of about 14%. Despite its rarity, the tumor can be misdiagnosed due to symptoms resembling dental issues and headaches, or it may even be asymptomatic. Radiologically, it presents a mix of radiolucent and radiopaque areas, sometimes unilocular or multilocular. Histopathologically, it is characterized by nests and sheets of polygonal epithelial cells with eosinophilic cytoplasm and prominent nucleoli. The presence of eosinophilic amyloid-like material and calcifications is distinctive, ranging from small concretions to larger aggregates. The exact origin of amyloids is unknown, but they are thought to derive from degraded keratin filaments. Treatment varies by tumor location, with more invasive procedures required for jaw tumors, including bone resection, due to their aggressive growth and invasion of the surrounding tissues. Accurate, individualized treatment is crucial for patient outcomes, particularly in cases where the tumor’s calcification is absent, indicating a severe impact on health. Our study included a case report of a 12-year-old patient who presented to the dental clinic complaining of sporadic pain in the area of the lower right front teeth. During a clinical examination of the area, we noticed a deformation of the alveolar bone, with a depressed mucosa. We followed the chronological steps of radiological examination, lesion excision, and histopathological examination to obtain a definitive diagnosis.

1 August 2025 in Medicina
Verified
Journal Article
Open access
PDF file
CMCarmen Aurelia Mogoantă
Carmen Aurelia Mogoantă
CSCodrut Sarafoleanu
Codrut Sarafoleanu
OAOsman Andrei
Osman Andrei
IEIrina Enache
Irina Enache
STShirley Tarabichi
Shirley Tarabichi
ITIonut Tanase
Ionut Tanase
Background and Objectives: Extramedullary plasmacytoma (EMP) is a rare monoclonal B-cell neoplasm that typically affects the head and neck region, with a predilection for the sinonasal tract. Clinical presentation is often nonspecific, leading to delayed diagnosis. This study aims to improve our understanding of sinonasal EMP by reviewing the recent literature and presenting a case series from our clinical experience. Materials and Methods: A systematic review of published cases of sinonasal EMP from 2000 to 2023 was conducted using the PubMed database, yielding 28 eligible cases. Additionally, we retrospectively analyzed three patients diagnosed and treated at our institutions. Inclusion criteria included histologically and immunohistochemically confirmed EMP without evidence of systemic multiple myeloma. Data on demographics, tumor location, symptoms, treatment, and outcomes were collected and analyzed descriptively. Results: Sinonasal EMP most commonly presented with unilateral nasal obstruction and epistaxis. Tumors were primarily located in the nasal cavity and paranasal sinuses, often extending beyond a single anatomical site. In the literature cohort, the most frequent treatment was combined surgery and radiotherapy (35.71%), followed by radiotherapy alone (17.86%). Recurrence was reported in 10.71% of cases, and 7.14% of patients died due to disease progression. All three patients in our case series underwent surgical excision; two received postoperative radiotherapy. No recurrences or progression to multiple myeloma were observed during follow-up (12–24 months). Conclusions: Sinonasal EMP is a rare but radiosensitive tumor with a favorable prognosis when treated with surgery and/or radiotherapy. Early diagnosis, histopathological confirmation, and exclusion of systemic disease are essential. Multidisciplinary management and long-term follow-up are critical due to the risk of recurrence and transformation into multiple myeloma.